Original Article

Title: COVID-19 symptoms are attenuated in atopic dermatitis patients treated with dupilumab

Short running title: Reduced COVID-19 symptoms in dupilumab-treated AD

Authors: Benjamin Ungar, MD¹; Jacob W. Glickman, MD^1*; Alexandra Golant, MD^1*; Celina Dubin, BA¹; Olga Marushchak, MA^1,2; Alyssa Gontzes, BS¹; Daniela Mikhaylov, BA¹; Giselle K. Singer, BS¹; Danielle Baum, RN¹; Nancy Wei, BA¹; Diana Gruenstein, BA¹; Mark G. Lebwohl, MD¹; Ana B. Pavel, PhD^1,3; Emma Guttman-Yassky, MD, PhD¹

Department of Dermatology and Laboratory of Inflammatory Skin Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Touro College of Osteopathic Medicine, New York, NY, USA
Department of Biomedical Engineering, The University of Mississippi, University, MS, USA

*Authors contributed equally